Skip to main content

Table 2 Baseline characteristics

From: Image analysis in posttreatment non-small cell lung cancer surveillance: specialists’ interpretations reviewed by the thoracic multidisciplinary tumor board

 

Total number of patients

n = 89

PET-CT

n = 45

CE-CT

n = 44

Age, years

65.3 (57.6-73.2)

67.6 (59.8-74.5)*

60.8 (56.6-70.1)*

Gender, female

27 (30.3)

16 (35.6)

11 (25)

Adenocarcinoma

57 (64)

30 (66.7)

27 (61.4)

NSCLC stage

 I

44 (49.4)

21 (46.7)

23 (52.3)

 II

24 (26.9)

14 (31.1)

10 (22.7)

 III

18 (20.2)

8 (17.8)

10 (22.7)

 IVa

3 (3.4)

2 (4.4)

1 (2.3)

Therapy

 Surgery alone

58 (65.2)

31 (68.9)

27 (61.4)

 Surgery + adjuvant chemoth.

19 (21.4)

7 (15.6)

12 (27.3)

 Surgery + neoadjuvant chemoth.

7 (7.8)

4 (8.9)

3 (6.8)

 Radiotherapy +/- chemoth.

2 (2.3)

1 (2.2)

1 (2.3)

 Other

3 (3.4)

2 (4.4)

1 (2.3)

Total number of surveillance studies

266

129

137

  1. Data presented as medians (IQRs) or numbers (%)
  2. PET-CT integrated F-fluorodeoxyglucose positron emission tomography-computed tomography, CE-CT contrast-enhanced computed tomography, NSCLC non-small cell lung cancer
  3. *p = 0.037 PET-CT vs. CE-CT
  4. asolitary brain metastasis